Launay O, Piat E, Bonduelle O, Bruhwyler J, et al. Phase 1, first-in-human, randomized, placebo-controlled, dose-escalating study to evaluate OVX033, a nucleocapsid-based SARS-CoV-2 candidate vaccine. J Infect Dis 2026 Aug 12:jiag409. doi: 10.1093.
PMID: 42583791